Ronald van Vollenhoven
Ronald van Vollenhoven
Less Is More: Hematologic Safety and Sustained Efficacy of a Modified Low-dose Etoposide Regimen in MAS [0.03%]
更少即是更多：低剂量依托泊苷改良方案治疗MAS的安全性和持续有效性
Zijun Ma,Xiaoquan Rao,Yingying Wei et al.
Zijun Ma et al.
Successfully treated mandibular osteomyelitis by TNF inhibitor in SAPHO syndrome [0.03%]
应用肿瘤坏死因子抑制剂成功治疗SAPHO综合征合并下颌骨炎一例
Seiya Oba,Tadashi Hosoya,Kota Yokoyama et al.
Seiya Oba et al.
Where we Live matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United States [0.03%]
居住地不同美国银屑病关节炎患者的疾病负担和治疗模式存在差异
Brittany Banbury,Sharon Dowell,Christopher Jenkins et al.
Brittany Banbury et al.
Objective: To evaluate the clinical characteristics, social deprivation, insurance coverage, and medication use across regional subsets of patients with psoriatic arthritis (PsA) in the US. ...
Reply to Letter to the editor A&R: "Negative" finding supports two-hit model, by Ronald van Vollenhoven [0.03%]
致编辑的信A&R：“阴性”结果支持两步模型——Ronald van Vollenhoven回应式文
Johanna M Kroese,Bernd W Brandt,Mark J Buijs et al.
Johanna M Kroese et al.
Reply to Letter to the Editor: "Systemic autoimmune rheumatic disease risk is associated with long-term exposure to fine particulate matter" [0.03%]
致编辑信回复：“细颗粒物长期暴露与系统性自身免疫风湿病风险有关”
Sasha Bernatsky,Naizhuo Zhao
Sasha Bernatsky
More Than Just ANA: Antibody Sialylation May Tip the Balance in Autoimmunity [0.03%]
不止是ANA：抗体岩藻糖基化可能影响自身免疫平衡
Raquel M Centeio,Taia T Wang
Raquel M Centeio
Yun Kyu Kim,Jeffrey R Curtis,Eun Bong Lee et al.
Yun Kyu Kim et al.
Comment on: Time-Dependent Effect of Prophylactic Trimethoprim-Sulfamethoxazole on the Incidence of Serious Infections in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Target Trial Emulation Study [0.03%]
对ANCA相关性血管炎中预防用复方新诺明对于严重感染发生率的时变效应的评论：靶向试验仿真的研究
Ivana Capuano,Eleonora Riccio,Pasquale Buonanno et al.
Ivana Capuano et al.
Longitudinal Autoantibody and Proteomic Profiles Uncover Biomarkers and Mechanisms of Disease Progression in Systemic Sclerosis [0.03%]
纵向自身抗体和蛋白质组特征揭示系统性硬化病进展的生物标志物和机制
Muyao Guo,Sijia Liu,Jing Huang et al.
Muyao Guo et al.
Objective: To evaluate dynamic changes in autoantibody and proteomic profiles in treatment-naïve systemic sclerosis (SSc) patients and identify biomarkers and mechanisms associated with disease progression. ...